Natural Product: NPC170597

Natural Product IDNPC170597
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
UKRDIRUVTNZWOU-AHTWRUMCSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 9830005
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives
          • [CHEMONTID:0000059] Coumaric acids and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey UKRDIRUVTNZWOU-AHTWRUMCSA-N
Standard InCHI InChI=1S/C29H36O13/c1-15-22(34)23(35)24(36)29(39-15)42-27-25(37)28(38-12-11-16-5-3-2-4-6-16)40-20(14-30)26(27)41-21(33)10-8-17-7-9-18(31)19(32)13-17/h2-10,13,15,20,22-32,34-37H,11-12,14H2,1H3/b10-8+/t15-,20+,22-,23+,24+,25+,26+,27+,28+,29-/m0/s1
SMILES C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]1[C@H]([C@H](OCCc2ccccc2)O[C@H](CO)[C@H]1OC(=O)/C=C/c1ccc(c(c1)O)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   592.22 Volume:   569.095
?
Van der Waals volume.
Dense:   1.041 LogP:   1.364
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.828
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.614
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   11.0 Rigid Bonds:   26.0
TPSA:   204.83
?
Topological Polar Surface Area.
H-Bond Acceptor:   13.0
H-Bond Donor:   7.0 Rings:   4.0
Heavy Atoms:   13.0

MedChem Properties

QED Drug-Likeness Score:   0.106 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.536 Fsp3:   0.483
MCE-18:   93.558
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   0.745 Fluc inhibitor:   0.661
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.181
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.439
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.206 Promiscuous compounds:   0.329

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.38 MDCK Permeability:   -5.267
Pgp-inhibitor:   0.0 Pgp-substrate:   0.144
PAMPA:   0.992
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.697
20% Bioavailability (F20%):   0.961 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.049 MRP1:   0.021
Plasma Protein Binding (PPB):   72.963% Volume Distribution (VD):   -0.524
Fu: 23.801%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.999
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.01
BSEP inhibitor:   0.004

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.001
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.002
CYP3A4-inhibitor:   0.025 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.933
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.501 Half-life (T1/2):  3.651

ADMET: Toxicity

hERG Blockers:  0.058 hERG Blockers (10um):  0.38
Human Hepatotoxicity (H-HT):  0.518 Drug-induced Liver Injury (DILI):  0.845
AMES Toxicity:  0.944 Rat Oral Acute Toxicity:  0.017
Maximum Recommended Daily Dose:  0.035 Skin Sensitization:  1.0
Carcinogencity:  0.057 Eye Corrosion:  0.0
Eye Irritation:  0.112 Respiratory Toxicity:  0.008
Drug-induced Neurotoxicity:  0.005 Ototoxicity:  0.987
Hematotoxicity:  0.232 Drug-induced Nephrotoxicity:  0.672
Genotoxicity:  0.389 RPMI-8226 Immunitoxicity:  0.052
A549 Cytotoxicity:  0.956 Hek293 Cytotoxicity:  0.656
BCF:   0.638
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.329
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.009
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.355
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota Roots n.a. n.a. PMID[22916954]
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO8101 Rehmannia glutinosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC170597 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8947 High Similarity NPC472350
0.8947 High Similarity NPC197316
0.8947 High Similarity NPC89105
0.8313 Intermediate Similarity NPC112
0.8293 Intermediate Similarity NPC269141
0.8205 Intermediate Similarity NPC46137
0.8193 Intermediate Similarity NPC252292
0.7619 Intermediate Similarity NPC263829
0.7586 Intermediate Similarity NPC100998
0.7381 Intermediate Similarity NPC76406
0.7356 Intermediate Similarity NPC298257
0.7356 Intermediate Similarity NPC175214
0.7349 Intermediate Similarity NPC483705
0.7294 Intermediate Similarity NPC611289
0.7262 Intermediate Similarity NPC134405
0.7241 Intermediate Similarity NPC34587
0.7229 Intermediate Similarity NPC483706
0.7191 Intermediate Similarity NPC34927
0.6966 Remote Similarity NPC205864
0.6966 Remote Similarity NPC247032
0.6923 Remote Similarity NPC96795
0.6923 Remote Similarity NPC264632
0.6848 Remote Similarity NPC300894
0.6848 Remote Similarity NPC23845
0.6703 Remote Similarity NPC296954
0.6702 Remote Similarity NPC106818
0.6667 Remote Similarity NPC473285
0.6477 Remote Similarity NPC68092
0.6429 Remote Similarity NPC87403
0.6264 Remote Similarity NPC106677
0.6211 Remote Similarity NPC610636
0.6207 Remote Similarity NPC81515
0.6098 Remote Similarity NPC886
0.6067 Remote Similarity NPC64141
0.6061 Remote Similarity NPC476381
0.604 Remote Similarity NPC306890
0.602 Remote Similarity NPC476384
0.6 Remote Similarity NPC470933
0.598 Remote Similarity NPC94871
0.5979 Remote Similarity NPC259347
0.5941 Remote Similarity NPC64195
0.5833 Remote Similarity NPC119537
0.5761 Remote Similarity NPC222433
0.5686 Remote Similarity NPC471062
0.5673 Remote Similarity NPC473427
0.5644 Remote Similarity NPC196063
0.5644 Remote Similarity NPC604195
0.5631 Remote Similarity NPC470934
0.56 Remote Similarity NPC476382
0.5588 Remote Similarity NPC476380
0.5543 Remote Similarity NPC205195
0.5521 Remote Similarity NPC476385
0.5495 Remote Similarity NPC235294
0.5474 Remote Similarity NPC476377
0.5472 Remote Similarity NPC229505
0.5392 Remote Similarity NPC476375
0.5349 Remote Similarity NPC287597
0.5294 Remote Similarity NPC141455
0.5229 Remote Similarity NPC476386
0.5179 Remote Similarity NPC257970
0.5161 Remote Similarity NPC260425
0.51 Remote Similarity NPC105005
0.5063 Remote Similarity NPC232880
0.5057 Remote Similarity NPC477294
0.5053 Remote Similarity NPC40305

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC170597 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8947 High Similarity NPD7266 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data